CRNX - Crinetics Pharmaceuticals GAAP EPS of -$0.85 misses by $0.01 revenue of $2.67M beats by $2.43M
2023-05-04 17:31:44 ET
- Crinetics Pharmaceuticals press release ( NASDAQ: CRNX ): Q1 GAAP EPS of -$0.85 misses by $0.01 .
- Revenue of $2.67M (-14.7% Y/Y) beats by $2.43M .
For further details see:
Crinetics Pharmaceuticals GAAP EPS of -$0.85 misses by $0.01, revenue of $2.67M beats by $2.43M